What are the side effects of Treosulfan-Grafapex?

Treosulfan - Grafapex is a drug used to treat acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but some side effects may occur during its use. Common adverse reactions include muscle and bone pain, stomatitis, fever, nausea, edema, infection and vomiting. These symptoms may affect the patient's daily life and require close attention during treatment.

In addition to the common adverse reactions mentioned above, patients also need to pay attention to abnormalities in non-hematology laboratory indicators when using trioxovan. For example, indicators such as gamma-glutamyl transpeptidase (GGT), bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and creatinine in liver function tests may increase, which may indicate damage to liver or kidney function and requires corresponding monitoring and evaluation.

Physicians and patients also need to be aware of some important warnings and precautions when using trioxovan. First, the drug may trigger seizures, so it should be used with caution, especially in patients with a history of epilepsy. In addition, adverse reactions such as skin diseases, injection site reactions and local tissue necrosis also need to be paid attention to and treated in time to avoid aggravation of the condition.

More importantly, use of trioxovan may increase the risk of secondary malignancies, especially with long-term treatment. Therefore, when receiving treatment, patients should fully communicate with their doctors, understand potential risks, and conduct regular examinations. At the same time, Trioxovan is also considered to have embryo-fetotoxicity, so you need to be extra careful when using it in female patients who are pregnant or planning to become pregnant, and be sure to follow the doctor's advice to avoid adverse effects on the fetus.

In short, Treosulfan-Grafapex is an anti-cancer drug. During its use, its side effects and potential risks should be comprehensively evaluated to ensure effective treatment and monitoring under the guidance of medical personnel to improve the patient's quality of life and treatment effect.

Reference materials:https://www.drugs.com/grafapex.html